Paper

Elucidation of the molecular mechanism of Sanguisorba Officinalis L. against leukopenia based on network pharmacology.

Published Nov 1, 2020 ·

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Rigorous Journal

Study Snapshot

Sanguisorba Officinalis L.'s molecular mechanism against leukopenia involves enhancing peripheral white blood cell production through PI3K-Akt, HIF-1, VEGF, and estrogen signaling pathways.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Elucidation of the molecular mechanism of Sanguisorba Officinalis L. against leukopenia based on network pharmacology.

References

Citations